Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Efficacy and safety of encorafenib (enco) plus binimetinib (bini) in patients with BRAF V600E-mutant (BRAF(V600E)) metastatic non-small cell lung cancer (NSCLC) from the phase 2 PHAROS study.
- Authors
- Riely, GJ[Riely, Gregory J.]; Smit, EF[Smit, Egbert F.]; Ahn, MJ[Ahn, Myung-Ju]; Felip, E[Felip, Enriqueta]; Ramalingam, SS[Ramalingam, Suresh S.]; Tsao, AS[Tsao, Anne S.]; Johnson, ML[Johnson, Melissa Lynne]; Gelsomino, F[Gelsomino, Francesco]; Esper, RM[Esper, Raymond M.]; Nadal, E[Nadal, Ernest]; Offin, M[Offin, Michael]; Provencio-Pulla, M[Provencio-Pulla, Mariano]; Otterson, GA[Otterson, Gregory Alan]; Dagogo-Jack, I[Dagogo-Jack, Ibiayi]; Alcasid, A[Alcasid, Ann]; Usari, T[Usari, Tiziana]; Wilner, KD[Wilner, Keith D.]; Pathan, N[Pathan, Nuzhat]; Johnson, BE[Johnson, Bruce E.]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.